NO2252275T3 - - Google Patents

Info

Publication number
NO2252275T3
NO2252275T3 NO09709833A NO09709833A NO2252275T3 NO 2252275 T3 NO2252275 T3 NO 2252275T3 NO 09709833 A NO09709833 A NO 09709833A NO 09709833 A NO09709833 A NO 09709833A NO 2252275 T3 NO2252275 T3 NO 2252275T3
Authority
NO
Norway
Application number
NO09709833A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2252275T3 publication Critical patent/NO2252275T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO09709833A 2008-02-13 2009-02-13 NO2252275T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2821808P 2008-02-13 2008-02-13
PCT/US2009/034162 WO2009103035A2 (en) 2008-02-13 2009-02-13 Templated open flocs of anisotropic particles for enhanced pulmonary delivery

Publications (1)

Publication Number Publication Date
NO2252275T3 true NO2252275T3 (https=) 2018-04-28

Family

ID=40955349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO09709833A NO2252275T3 (https=) 2008-02-13 2009-02-13

Country Status (7)

Country Link
US (7) US12263243B2 (https=)
EP (1) EP2252275B1 (https=)
AU (1) AU2009214443B2 (https=)
CA (1) CA2723314C (https=)
DK (1) DK2252275T3 (https=)
NO (1) NO2252275T3 (https=)
WO (1) WO2009103035A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2252275T3 (https=) 2008-02-13 2018-04-28
CA2754691C (en) 2009-03-26 2019-07-30 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
US8506799B2 (en) * 2009-09-09 2013-08-13 ClearCorp Suspended particle characterization system for a water processing facility
US9248110B2 (en) 2010-03-18 2016-02-02 Steven Lehrer Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis
US20110229418A1 (en) * 2010-03-18 2011-09-22 Steven Lehrer Compositions and Methods of Treating and Preventing Lung Cancer
US9228785B2 (en) 2010-05-04 2016-01-05 Alexander Poltorak Fractal heat transfer device
EP2464346A1 (en) 2010-08-30 2012-06-20 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
AU2011296343B2 (en) 2010-08-30 2015-12-10 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
EP3470057B1 (en) 2010-09-29 2021-11-03 Pulmatrix Operating Company, Inc. Cationic dry powders comprising magnesium salt
RU2017144619A (ru) 2010-09-29 2019-02-20 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
CN104274427A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 格拉司琼气溶胶组合物及其用途
CN104274426A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
US10307370B2 (en) 2013-10-08 2019-06-04 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
ES2922206T3 (es) 2014-02-20 2022-09-09 Otitopic Inc Formulaciones de polvo seco para la inhalación
DK3125875T3 (da) 2014-04-04 2023-07-24 Ai Therapeutics Inc Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
ES2942297T3 (es) 2014-07-31 2023-05-31 Vectura Inc Formulaciones de polvo seco para inhalación
KR20170095807A (ko) 2014-10-07 2017-08-23 램 테라퓨틱스, 인코포레이티드 폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제
JP6940416B2 (ja) * 2015-05-01 2021-09-29 ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System 多剤脆性マトリックス組成物
EA201890618A1 (ru) 2015-09-01 2018-10-31 Ферст Вэйв Байо, Инк. Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами
EP3440019A4 (en) * 2016-04-08 2019-02-13 Remirez, Jose, Antonio SYSTEM AND METHOD FOR AUTOMATED DOSAGE WITH LIGHT PROFILING FOR WASTEWATER FILTRATION SYSTEM
EP3485215B1 (en) 2016-07-12 2023-06-07 Alexander Poltorak System and method for maintaining efficiency of a heat sink
EP3525759A1 (en) 2016-10-14 2019-08-21 Pulmatrix Operating Company, Inc. Antifungal dry powders
US11918646B2 (en) 2017-12-11 2024-03-05 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2019204568A1 (en) * 2018-04-20 2019-10-24 Board Of Regents, The University Of Texas System Apparatus and methods for characterizing plume geometry
US12091313B2 (en) 2019-08-26 2024-09-17 The Research Foundation For The State University Of New York Electrodynamically levitated actuator
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
TW202200121A (zh) 2020-03-16 2022-01-01 美商費斯特威弗生技股份有限公司 治療方法
US12076328B2 (en) 2020-04-01 2024-09-03 Board Of Regents, The University Of Texas System Pharmaceutical compositions of niclosamide
EP4138791A1 (en) * 2020-04-20 2023-03-01 Board of Regents, The University of Texas System Biologically active dry powder compositions and method of their manufacture and use
WO2021242675A1 (en) 2020-05-26 2021-12-02 Gradalis, Inc. Methods for the treatment of viral respiratory infections
WO2022055817A1 (en) 2020-09-09 2022-03-17 Gradalis, Inc. Composition formulated into inhalable dosage forms for the treatment of lung|tumors
CA3219943A1 (en) 2021-05-12 2022-11-17 Tff Pharmaceuticals, Inc. Dry powder formulations of tacrolimus for administration by inhalation once daily (qd)
JP2024534185A (ja) * 2021-08-30 2024-09-18 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム モノクローナル抗体乾燥粉末
US20230112800A1 (en) 2021-08-31 2023-04-13 Board Of Regents, The University Of Texas System Delayed release niclosamide formulation
WO2024059819A2 (en) 2022-09-15 2024-03-21 Tff Pharmaceuticals, Inc. Compositions of cannabinoids for delivery by inhalation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6284282B1 (en) 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6585957B1 (en) 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
AR028746A1 (es) 2000-06-23 2003-05-21 Norton Health Care Ltd Cartucho de dosis previamente medidas para inhalador de polvo seco accionado por la respiracion, el inhalador y un metodo de provision de dosis previamente medidas de polvo seco
JP2003146523A (ja) 2001-11-15 2003-05-21 Canon Inc 画像形成装置
EP1501483A2 (en) 2002-04-25 2005-02-02 Nektar Therapeutics UK Ltd Particulate materials
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
WO2004030659A1 (en) 2002-09-30 2004-04-15 Acusphere, Inc. Sustained release porous microparticles for inhalation
MXPA05007156A (es) * 2002-12-31 2005-09-21 Nektar Therapeutics Formulacion farmaceuticas aerosolizable para terapia para infecciones fungicas.
EP1589948A1 (en) 2003-01-15 2005-11-02 Dow Global Technologies Inc. Drug particles obtained by freezing onto a cold surface
CA2538237A1 (en) 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
US9061027B2 (en) 2004-08-27 2015-06-23 Board Of Regents, The University Of Texas System Enhanced delivery of drug compositions to treat life threatening infections
CN101687044B (zh) * 2007-05-25 2014-10-29 不列颠哥伦比亚大学 用于口服给药的治疗剂的制剂和相关方法
NO2252275T3 (https=) * 2008-02-13 2018-04-28

Also Published As

Publication number Publication date
US11364197B2 (en) 2022-06-21
EP2252275A4 (en) 2013-11-06
US20090208582A1 (en) 2009-08-20
WO2009103035A3 (en) 2009-11-12
EP2252275A2 (en) 2010-11-24
WO2009103035A2 (en) 2009-08-20
US20250127717A1 (en) 2025-04-24
US20200069572A1 (en) 2020-03-05
DK2252275T3 (en) 2018-03-05
US10434062B2 (en) 2019-10-08
US20220354778A1 (en) 2022-11-10
US20190117557A1 (en) 2019-04-25
AU2009214443A1 (en) 2009-08-20
EP2252275B1 (en) 2017-11-29
US12029816B2 (en) 2024-07-09
US20210007971A1 (en) 2021-01-14
AU2009214443B2 (en) 2013-10-10
US10660850B2 (en) 2020-05-26
CA2723314A1 (en) 2009-08-20
US20100221343A1 (en) 2010-09-02
US12263243B2 (en) 2025-04-01
CA2723314C (en) 2017-01-10
US10092512B2 (en) 2018-10-09

Similar Documents

Publication Publication Date Title
BR112016019572A2 (https=)
BRPI0909040A2 (https=)
BRPI0917573A2 (https=)
BRPI0908549B8 (https=)
BRPI0918697A2 (https=)
BRPI0917525A2 (https=)
BRPI0920750A2 (https=)
BRPI0919470A2 (https=)
BRPI0907698A2 (https=)
BRPI0917618A8 (https=)
BRPI0922455A2 (https=)
BRPI0923734A2 (https=)
BRPI0912727A2 (https=)
BRPI0922669A2 (https=)
BRPI0908285A2 (https=)
BRPI0910485A2 (https=)
BRPI0914750A2 (https=)
BRPI0919811A2 (https=)
BRPI0915616A2 (https=)
BRPI0908120A2 (https=)
BRPI0904541A8 (https=)
BRPI0912462A2 (https=)
BRPI0920914A2 (https=)
BRPI0922550A2 (https=)
BRPI0916284A2 (https=)